Pentobarbital will decrease the extent or outcome of linagliptin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. Use of different treatment plans is strongly recommended when linagliptin will be to be administered with a CYP3A4 inducer pentobarbital will lower the extent or influence of elbasvir/grazoprevir by affecting hepatic/intestinal enzyme CYP3A4 https://deborahr570ept8.jts-blog.com/profile